Kanbi  Pharma  Teknoloji  Limite
1629229-37-3 Fezolinetant

1629229-37-3 Fezolinetant

CAS: 1629229-37-3
MF: C16H15FN6OS
MW: 358.39
Einecs:
MDL No.:MFCD30532641

Voye rechèch
Dekri teren

Pwopriyete

Aparans blan ak jòn solid
Pwen bouyi: 623. 0 ± 65. 0 degre
Dansite 1.56 ± 0. 1 g/cm3
Depo tanperati. Magazen nan -20 degre
solubility dmso: 2 0. 0 (max conc. mg/ml); 55.8 (max conc. mm)
PKA {{0}}. 28 ± 0.40

 

Aplikasyon:

Fezolinatant (non komès Veozah) se yon medikaman ki pa ormon ki itilize pou trete sentòm vasomotor modere ak grav (VMs) ki te koze pa menopoz. Li se yon antagonist reseptè NK3 ki prensipalman kontwole aktivite nerono nan sant la thermoregulatory pa antagonize neurokinin la -3 reseptè (NK3 reseptè), kidonk soulaje sentòm VMS

 

Sinonim:

Fezolinetant

1629229-37-3

ESN364

Veozah

ESN -364

fezolinetantum

A2693

(4- fluorophenyl)-[(8r) -8- methyl -3- (3- methyl -1, 2, 4- yl) -6, 8- dihydro -5 h- [1,2,4] triazolo [4, 3- a] pyrazin -7- yl] methanone

(R)-(4- fluorophenyl) (8- methyl -3- (3- methyl -1, 2, 4- thiadiazol -5- } yl) -5, 6- dihydro- [1,2,4] triazolo [4, 3- a] pirazin -7 (8h) -yl) methanoneone

A-2693

Kòm -3472693-00

Metanon, ((8r) -5, 6- dihydro -8- methyl -3- (3- methyl -1, 2, 4- thiadiazol {{9} yl) -1, 2, 4- triazolo (4, 3- a) Pyrazin -7 (8h) -yl) (4- fluorophenyl)-

(4- fluorophenyl) ((8r) -5, 6- dihydro -8- methyl -3- (3- methyl -1, 2, {{{{{ {9}} thiadiazol -5- yl)-(1,2,4) Triazolo (4, 3- a) Pyrazin {{17}

Veoza

Vezoa

GTPL10422

ESN 364

 

Baj popilè: 1629229-37-3 Fezolinetant, Lachin 1629229-37-3 Konpayi fabrikasyon Fezolinetant, Swèd

Inquiry
goTop

(0/10)

clearall